A Post Marketing Surveillance Study on the Safety and Effectiveness of Prucalopride in the Treatment of Chronic Constipation

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

December 31, 2014

Conditions
Chronic Constipation
Interventions
DRUG

Prucalopride

Prucalopride 2 mg tablet/day orally for 12 weeks. For elderly patients (\>65 years old), patients with renal impairment not requiring dialysis or patients with severe hepatic impairment, 1mg prucalopride once daily should be given.

Trial Locations (7)

Unknown

City of Muntinlupa

City of Taguig

Makati City

Manila

Marikina City

Quezon City

San Juan City

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutica

INDUSTRY